| Jun 20 |
Collegium Pharmaceutical (NASDAQ:COLL) shareholders have earned a 19% CAGR over the last five years
|
| Jun 13 |
Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
|
| Jun 10 |
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Upgraded by Jefferies
|
| Jun 9 |
Street calls of the week: Upgrades for Best Buy and Lululemon
|
| Jun 7 |
Jefferies upgrades Collegium to buy, cites upside related to LOEs
|
| Jun 6 |
Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 25,000 Shares of Collegium ...
|
| May 30 |
Insider Sale: EVP & CFO Colleen Tupper Sells Shares of Collegium Pharmaceutical Inc (COLL)
|
| May 29 |
Collegium to Participate in Jefferies Global Healthcare Conference
|
